Skip to main content

Esther DeRoot

Analyst

Barclays

Equibles does not estimate personal net worth.

About Esther DeRoot

Esther DeRoot is recorded as Analyst at Barclays. Esther DeRoot has spoken on 1 earnings call and 1 other investor event across 2 companies, most recently for Anaptysbio, Inc on March 10, 2026. Those appearances were for Anaptysbio, Inc (ANAB) and Syndax Pharmaceuticals Inc (SNDX). The companies whose calls Esther DeRoot spoke on are classified in the Healthcare sector.

Esther DeRoot on recent calls

“My pleasure to have Anaptis Bio CEO Dan Fager with us this morning. And maybe just to kick us off, Dan, if you could just give us an overview of Anaptis Bio for those less familiar with the story.”
Analyst — Barclays, Barclays 28th Annual Global Healthcare Conference ·
“Just quickly going back to earlier, Tom, And just wondered what you're seeing with regard to the most common combo agents being used currently. And then also, you know, exiting sort of the quarter, what average duration of therapy are you seeing?”
Analyst — Barclays, Syndax Pharmaceuticals Inc Q4 FY2025 Earnings Call ·

Affiliation history

  • Barclays

    Analyst

    Source not stated

    Current

Company network

Recent activity